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DRG: Dorsal Root Ganglia 
SN: Sciatic Nerve 
SC: Spinal Cord 
BBB: Blood Brain Barrier 
CNS: Central Nervous System 
PNS: Peripheral Nervous System 
IT: Intrathecal 
TLR4: Toll-Like Receptor 4 
TLR4 activation leads to an intracellular signaling pathway and the release of 
inflammatory cytokines that are together responsible for activating the immune system 
LPS: Lipopolysaccharide  
Part of bacterial cell wall that is an inflammatory TLR4 agonist. 
WT: Wild Type 
Cc2-/-: C-C Chemokine Receptor Type 2 
Transgenic mice that lack this gene do not express the CCR2 receptor that is responsible 
for recruiting circulating macrophages and monocytes to the DRG during an immune 
response 
Iba1: Allograft Inflammatory Factor 1  
Microglia antibody that is also present on macrophages 
MCH II: Major Histocompatibility Complex, class II  
Antibody present on endothelial cells 
CX3CR1: Chemokine (CX3C) Receptor, class I 
Gene that encodes for the receptor of chemokines (CX3XCR1) and fraktaline ligands that 
are present on macrophages 
NMDA: N-Methyl-D-Aspartate Receptor 
GFAP: Glial Fibrillary Acidic Protein 
 Protein expressed by astrocytes (CNS) and glial cells (PNS) 
ATP: Adenosine Triphosphate 
An important extracellular signaling molecule that acts as a neurotransmitter in the PNS 
and the CNS. ATP is released from synaptic terminals and causes post-synaptic currents 
NeuN: Neuronal Nuclear Protein 
 Target for fluorescent staining of neuronal nuclei. 
DAPI: 4′,6-Diamidino-2-Phenylindole 
Fluorescent stain that binds strongly to adenine–thymine-rich regions in DNA and allows 
visualization of cell nuclei. 
t-SNE plots: T-distributed Stochastic Neighbor Embedding  
A machine learning algorithm for visualization of high-dimensional data in 2- or 3-
dimensional space 
3D: Three Dimensional 
 
  




The present study examined morphological changes in the dorsal root ganglia (DRG) following 
an innate immune stimulus. The importance of the DRG has increasingly become recognized in 
pain processing as more than just the home of primary afferent cell bodies. All sensory 
information passes through the DRG via the primary afferents, and on to the spinal cord. The 
primary afferents synapse with second-order neurons in the spinal cord that ascend towards the 
brain, where they transmit the pain signal to the limbic forebrain and/or the somatosensory 
cortex for processing. The DRG is an interesting niche to study at as it lies outside the blood-
brain-barrier (BBB) but projects to the CNS. Therefore, neurons in the DRG are exposed to large 
circulating molecules (such as LPS) that normally would not be able to act on second-order 
neurons in the spinal cord, due to the BBB, and thus can indirectly act on second-order neurons 
by sensitizing their primary afferent inputs, which increases primary afferent output into the 
spinal cord. Of particular interest, the DRG constitutively possesses a significant population of 
macrophages. Mice injected with lipopolysaccharide (LPS) will lead to an enhanced pain 
response that has been speculated to result from the activation of innate immune receptors (TLR4 
expressed on the macrophage which leads to the release of active factors that sensitize the 
sensory neuron). To enable study of these DRG macrophages, we employed a novel 3D imaging 
technique to visualize morphological changes in whole cells, as opposed to previous imaging 
methods that only captured slices of cells, which greatly improved our ability to depict the dense 
and complex cellular environment of the DRG. A machine learning network was employed to 
train 3D stacks of DRG tissue images at different depths and intensities. After running thousands 
of replicates (epochs), through curated images, the machine learning program became very 
accurate and enabled us to characterize, in 3D reconstructions, the DRG macrophage population. 
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This approach enabled several observations. 1) Two distinct sub-populations of macrophages in 
the DRG were found: non-vascular and peri-vascular macrophages. 2) Spinal delivery of LPS 
which activated TLR4 receptors was found to increase the size of the individual macrophages, 
but in contrast to previous studies no the number. 3) This change in macrophage size vs. number 
was confirmed by the lack of change in the macrophage response in CXC3R (-) mutants which 
do not have circulating macrophages. The macrophage production of many spiny, amorphic 
processes were likely “double counted” in previous studies done on tissue slices (as opposed to 
the 3D, whole-cell modeling employed in these studies). By visualizing whole 3-D reconstructed 
cells, we were able to differentiate between increases in macrophage number versus increased 
macrophage volume that manifested. These techniques were validated by comparing our data 
analysis pipeline with commercially-available software, which yielded similar results. Further 
application, of our techniques and pipeline will enable the 3D imaging of different cell types and 
their interactions within the DRG.  
Keywords: DRG, chronic pain, peripheral sensitization, central sensitization, 
macrophages, satellite glial cells, cytokines, chemokines, LPS, 3D image pipeline 
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Background: Pain as a problem  
Chronic pain (>3 months) arises from a variety of disease states such as arthritis, cancer, 
osteoporosis, back pain, and nerve injury, cumulatively effecting over 126 million people 
globally. Not only does chronic pain diminish quality of life, it contributes to a loss of substantial 
economic productivity (Gaskin & Richard, 2012). Chronic pain has also been associated with 
psychological conditions like depression and anxiety, impacting even more people around the 
world. Pain therapy, and its efficacy, varies greatly, in part, due to the distinct and disparate 
mechanisms that underlie different pain states. While many analgesic drugs (e.g. opioids) 
provide effective short-term pain relief, they are less effective and have undesirable side effects 
when employed chronically, which is necessary in the treatment of persistent pain (Rosenblum et 
al., 2008). This decreased efficacy is due to a multitude of reasons including tolerance, 
dependence and addiction. Understanding pain perception in humans is crucial for the 
development of analgesics and therapeutic strategies for pain reduction. In this thesis, I will 
explain the larger pain circuit in general, and then introduce one component of the pain pathway 
that has been identified as a potentially effective target area for novel chronic pain therapies – the 
dorsal root ganglion. 
Nociception and pain processing 
A high intensity stimulus that induces the transmission of a pain signal represents the 
activation of a series of neuronal linkages. First, primary sensory neurons that respond 
selectively to high intensity thermal and mechanical stimuli (e.g A∂ nociceptive specific 
afferents and small unmyelinated C polymodal nociceptors) project to the spinal cord and 
synapse with second order neurons in the superficial dorsal horn. In these nociceptors, the 
frequency of discharge covaries directly with the stimulus intensity. The second order neurons, 
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activated by primary afferents (again with their frequency of discharge covarying directly with 
stimulus intensity), send their axons contralaterally to ascend in the anterolateral pathway to 
several regions of the thalamus.  Here, third order neurons in lateral thalamic nuclei project to the 
somatosensory cortex, while third order neurons in the more medial thalamic nuclei project to 
cortical regions such as the anterior cingulate and inferior insula. Importantly, the somatosensory 
regions are thought to mediate perception of the location and intensity of the stimulus (so called 
sensory discriminative components), while the other regions (part of the “old limbic forebrain”) 
are thought to underlie emotion and affective aspects that correspond to sensory perception of the 
stimulated area.  
The shape of the primary afferent 
Sensory primary neurons are pseudo unipolar, meaning that two axonal branches project 
from the neuron’s cell body: one longer axon innervating peripheral tissue and the other 
projecting centrally to synapse in the dorsal horn. During embryogenesis, the cell body buds off 
from the sensory axon, retaining connection with the axon by a glomerulus that links the cell 
body to the axon. This glomerulus serves as the route by which the products (e.g. protein, 
metabolic products, enzymes, etc.) synthesized in the cell body are transported to the axon. 
Further, the glomerulus can transmit action potentials from the cell body through the proximal 
branch in passage to the spinal cord, and conversely can receive conducted potentials originating 
from the proximal or distal terminals (Nascimento et al., 2018). All sensory information detected 
in the periphery is sent by the innervating afferents, passing though their respective DRGs, to 
synapse in the dorsal horn. (Lu & Richardson, 1993; Nascimento et al., 2018) 
Sensitization and chronic pain  
3D imaging of DRG macrophages 
	
8 
It has been observed that in the setting of tissue injury and inflammation, the relationship 
between stimulus intensity and pain behavior is altered such that a given stimulus yields a 
stronger pain response. This enhanced response, referred to as hyperalgesia or allodynia 
(hyperalgesia: excessive sensitivity to mildly noxious input, and allodynia: low-intensity 
mechanical stimuli yields a pain response), reflect two mechanisms: peripheral and spinal 
sensitization.   
Peripheral sensitization follows tissue injury and inflammation, when afferent activation 
and discharge is altered such that the otherwise silent nociceptor begins to display spontaneous 
activity and an augmented frequency–stimulus intensity response relationship (e.g a left shift in 
the stimulus-intensity response curve) (Xie et al., 2007). Consequentially, a modest, non-
aversive, low-intensity, stimulus may generate an augmented afferent discharge that leads a 
stimulus to be perceived as painful when it normally would not. This enhanced afferent response 
is caused by a sensitization of the primary afferent terminal generated by the local release of 
active factors such as hydrogen ions, kinins, chemokines and cytokines arising from tissue 
injury, capillary leakage, and the in-migration of inflammatory cells (Grace et al., 2011; Kiguchi 
et al., 2012; Milligan et al., 2001). 
Spinal sensitization occurs when the intense, high-frequency afferent barrage generated 
by injury and inflammation leads to a sensitization of the dorsal horn second order projection 
neurons. This sensitization of the second order neurons reflects a number of underlying pain 
mechanisms. As an example, high frequency afferent input leads to depolarization of the second 
order neuron that lay deep in the dorsal horn and which are referred to as wide dynamic range 
neurons. These cells are activated by glutamate released from small afferents displaying high 
frequency output and this leads to massive depolarization though the activation of the NMDA 
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receptor. This phenomenon is known as wind up. Further, the increase of NMDA activation 
leads to increases in intracellular calcium that serve to activate kinases that phosphorylate 
channels and receptors increasing their activation. Activation of enzymes that release lipids like 
prostaglandin sensitize local neuronal membranes and then initiate further transcription leading 
to the upregulation of a variety of pro-excitatory channels and receptors (Ji et al., 2012; Peters et 
al., 2006; Milligan et al., 2001). In addition, this massive excitation serves to activate non-
neuronal cells in the dorsal horn such as astrocytes and microglia which themselves release pro-
inflammatory cytokines. The chemical cascades initiated by the injury-induced high frequency 
input results in increases in the transmittal system (Simeoli et al., 2017; Kiguchi et al., 2012; Ji et 
al., 2012). Here the enhanced response to an otherwise innocuous stimulus (allodynia or 
hyperalgesia) is fundamentally driven by central and peripheral sensitization. A third element in 
this cascade is the role played by the afferent cell bodies in the DRG.   
Figure 1: Visual representation of pain processing following tissue injury. As part of the immune response, pro-inflammatory mediators 
are released by capillaries, endothelial cells, macrophages, ETC. which act on the nociceptive afferent and effectively sensitize the neuron 
such that any sensory input triggers augmented afferent discharge into the spinal cord. Augmented discharge into the spinal cord 
depolarizes the secondary afferent and causes the recruitment of immune cells, like astrocytes and microglia, that further sensitize 
secondary afferents projecting to the brain. All sensory input detected on the periphery is sent through the DRG before reaching the 
spinal cord. The DRG is home to a complex environment of neuronal somas, SGCs, macrophages, and endothelial cells. The DRG lies 
outside of BBB but sends projections into the CNS, enabling peripheral input to induce changes in the protected CNS environment. 
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The Dorsal root ganglion (DRG)   
The DRGs are composed of the afferent cell bodies (somas) that provide sensory 
innervation for each of the spinal segments. These DRGs are located in the foramen formed at 
the junctures of each pair of vertebral bodies. The DRG is unique in that it lies outside the blood 
brain barrier (BBB) of the central nervous system (CNS), making it a novel and distinctive 
neuraxial system to study pain transmission. Of particular interest has been the appreciation that 
the DRG neuron, when activated by mechanical stimuli (as with a disc avulsion) or the presence 
of inflammatory products, is able to generate afferent activity that leads to an output to the dorsal 
horn (Xie et al., 2007; Peters et al., 2006). Thus, consider that one characteristic feature of the 
primary afferent nociceptors is their uniform silence in the absence of adequate stimulation. 
However, after tissue and nerve injury, many studies have demonstrated abnormal spontaneous 
activity of primary sensory neurons originating at the site of injury (Xie et al., 2007; Lu & 
Richardson, 1993; Milligan et al., 2001). It is appreciated that this spontaneous, or ectopic 
activity, can originate from the peripheral terminals (as at the site of local nerve injury) and that 
prolonged activity may also arise from the neuronal cell body in the DRG of the injured axon 
(Kiguchi et al., 2012; Xie et al., 2007; 
Peters et al., 2006).  
The origin of this ectopic afferent 
activity in the DRG appears to reflect the 
roles played by complex elements found 
within the DRG. The DRG thus provides an 
interesting collection of effects for pain 
transmission as it lies outside of the BBB 
Figure 2: Visualization of the complex environment of the DRG. 
Neuronal cell bodies are stained for the antigen NeuN (red) that is 
present in neuronal nuclei. The nuclei of other cells, including 
glia, vascular cells, and inflammatory cells, are stained with the 
DNA-binding dye - DAPI (blue). 
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(in the PNS), such that its vasculature, unlike that in the CNS, does not have tight junctions, 
exposing the DRG to peripherally circulating substances that could not originally enter the spinal 
parenchyma and cause central sensitization (Jimenez-Andrade et al., 2008). These DRG 
components will be reviewed below. 
DRG Satellite cells (GFAP +) 
It is well known that neural activity enhances the release of trophic factors by regulatory 
cells surrounding neurons – a process that has implicated the complex DRG environment in the 
sensitization of primary afferent cell bodies (Kiguchi et al., 2012; Jimenez-Andrade et al., 2008). 
The DRG is classically thought of as the home of neuronal cell bodies but anatomically they are 
also comprised of large populations of satellite glial cells (SGCs) and macrophages that also 
exist in the DRG (Lu & Richardson, 1993, Ji et al., 2012). These SGCs lay in very close 
proximity to the DRG afferent cell body and are referred to as the “resident astrocytes” of the 
PNS as they form astrocyte-like gap junctions with somas in the DRG and exhibit astrocyte-like 
behaviors such as clearing debris, releasing trophic factors, recycling neurotransmitters, and 
modulating synaptic strength but uniquely, they reside outside of the BBB (Ji et al., 2012). 
Satellite glial cells in the DRG form neuron-glia units with primary afferent cell bodies via gap 
junctions such that the distance between the SGC and the neuronal soma is only 20 nm (Pannese, 
2013; Ji et al., 2012). Communication through these gap junctions is enhanced in persistent pain 
conditions (Hu & McLachlan, 2002, Ji et al., 2012) and results in the up-regulation of channels 
and receptors (e.g. NMDA, ATP, Iba1, TLRs and chemokine receptors) on SGCs that can be 
activated by substances secreted by DRG somas (Ji et al., 2012; Kiguchi et al., 2012; Pannese, 
2013).  Many studies have demonstrated bidirectional communication between primary afferent 
cell bodies in the DRG and glial cells, and this communication has been correlated with changes 
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in primary afferent spontaneous activity (Nascimento et al., 2018; Hu & McLachlan, 2002; 
Kiguchi et al., 2012). Data suggests that SGCs respond to spontaneous activity with an elevation 
of internal calcium concentration that leads to the release of neurotransmitters, causing feedback 
regulation of neuronal activity. Additionally, SGCs have been observed to activate primary 
afferents through the release of ATP, which plays an important role in peripheral sensitization (Ji 
et al., 2012). Trophic factors such as cytokines, chemokines, and growth factors released in the 
DRG after injury alter the morphology and sensitization of glia-neuron units in the DRG such 
that SGCs may play a key role in persistent augmented afferent output into the dorsal root of the 
spinal cord causing central sensitization (Hu & McLachlan, 2002; Pannese, 2013). 
DRG Macrophages (Iba1 +) 
Macrophages are considered the “resident microglia” cells of the PNS as their phenotype 
mimics that of microglia in the CNS but they reside outside of the BBB (Ji et al., 2012). 
Microglia in the CNS have been extensively studied and are known to activate following injury, 
causing them to up-regulate Iba 1 and MHC-II receptors, change their morphology, and 
proliferate (Grace et al., 2011; Kiguchi et al., 2012; 68). Microglia activate following both direct 
damage to the CNS and damage to the peripheral nerve, suggesting that peripheral injury can 
induce morphological changes in and communication to the spinal cord (Peters et al., 2006). 
Injury-induced microglia changes are associated with neuropathic pain such that blocking 
microglia following peripheral nerve injury can prevent central sensitization (Grace et al., 2011; 
Kiguchi et al., 2012; Ji et al., 2012; Pannese, 2013). 
Distinct populations of macrophages exist all throughout the body, cleaning synapses 
through phagocytosis but behaving slightly differently based on the demands of their 
environment (Grace et al., 2011; Kiguchi et al., 2012). The supportive role of macrophages in 
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general is through the consumption and subsequent removal of harmful debris surrounding 
neurons, preventing Wallerian degeneration (Kiguchi et al., 2012; Lu & Richardson, 1993).  
Macrophages present a third cell population present in the DRG that could act on afferent 
somas and contribute to increased afferent output into the spinal cord such as SGCs and somas 
themselves. Macrophages makeup 5% of the volume of the DRG such that their potential role in 
regulating sensory afferent activation through interactions with DRG somas is underappreciated 
with respect to their number and microglia-like functioning (Lu & Richardson, 1993). Activated 
macrophages can release several families of active molecules that can act upon primary afferent 
somas to enhance their excitability. Previous research has noted that DRG cell bodies release 
vesicles containing microRNA that are thought to recruit macrophages to the DRG following 
peripheral nerve injury. Altered macrophage-neuron interactions as such has correlated with the 
extent of hypersensitivity (Simeoli et al., 2017; Kiguchi et al., 2012). 
Peripheral nerve damage activates two distinct populations of macrophages: one at the 
site of injury and one around the afferent cell bodies in the ipsilateral DRG (Yu et al., 2020; Lu 
& Richardson, 1993; Simeoli et al., 2017). The contribution of altered macrophage functionality 
in response to nerve injury is not fully understood but research suggests that changes in DRG 
macrophages that initiate and maintain mechanical hyper sensitivity around afferent cell bodies 
persist longer than macrophage activation at the site of nerve injury (Yu et al., 2020; Lu & 
Richardson, 1993; Hu & McLachlan, 2002). Macrophages release pro-inflammatory mediators 
such as cytokines and chemokines that activate the vascular endothelium and alter nociceptive 
transduction such that sensory afferents become active (Simeoli et al., 2017; Grace et al., 2011; 
Hu & McLachlan, 2002).  
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The actions and particular role of macrophages in neural pain responses has been 
disputed in existing research but one common finding is the proliferation of macrophages in the 
DRG following nerve injury (Lu & Richardson, 1993; Simeoli et al., 2017; Hu & McLachlan, 
2002; Peters et al., 2006; Pannese, 2013). Like microglia, macrophage proliferation and 
expansion after nerve damage is hypothesized to enhance their effect on pain transduction. 
Studies have proposed that an increase in macrophages around the peripheral terminal can be 
beneficial for axon regeneration (Lu & Richardson, 1993) while an increase in macrophages in 
the DRG has correlated with afferent sensitization and persistent pain (Lu & Richardson, 1993; 
(Hu & McLachlan, 2002; Yu et al., 2020). Regardless of their specific effects on afferent 
transmission, extensive changes in macrophage number, shape, and function following nerve 
injury prompts an investigation into the extent of neuron-glia-macrophage changes and 
interactions and their contribution to pain processing.  
DRG Vasculature 
Because the DRG lies outside of the BBB and encapsulates many blood vessels, 
circulating products in the blood stream, that would normally be unable to affect central 
processing, can act on primary afferent cell bodies in the DRG that project to the CNS. If 
macrophages act on primary afferent cell bodies in the DRG, their previously studied interactions 
with blood vessels could enable them to act as a conduit for circulating large molecules into the 
DRG. While inflammatory molecules like LPS usually could not be transmitted across the BBB 
and into the CNS, uptake of LPS by local macrophages in the DRG or macrophages that migrate 
into the DRG after injury could sensitize primary afferents by releasing LPS onto cell bodies.  
Previous research has indicated that macrophages typically lay in very close proximity to the 
DRG vasculature (Jimenez-Andrade et al., 2008; Lu & Richardson, 1993). Additionally, DRG 
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blood vessels receive sympathetic innervation from other peripheral tissues that could further 
cause the sensitization of macrophages through some effect of their interaction. 
Macrophages as potential targets for pain therapy  
Drugs have been developed that isolate peripheral or DRG macrophages, leaving the 
CNS environment un-altered due to the protection of the BBB. For example, the FK-binding 
protein dimerizer, AP20187, selectively kills macrophages in mice by manipulating the CSF1R 
promoter that is expressed by monocytic cells (Yu et al., 2020). For this reason, to the extent that 
activated DRG macrophages serve to augment injury-induced activation or become ectopic 
generators themselves, macrophage targeted interventions present a possible strategy for 
therapeutic intervention with regard to chronic pain. These DRG macrophages have received 
relatively little attention in the neuroscience community but appear to play a large role in the 
regulation of peripheral cells and could therefore pose therapeutic benefits from the perspective 
of peripheral aid, not impacting the CNS or neurons.  
DRG and macrophage imaging 
DRGs are densely packed with neuronal soma, fibers, satellite glial cells, macrophages, 
and blood vessels that lack any specific organization. The DRG also lacks definite anatomic land 
marks to orient sectioning, making it difficult to know what part of DRG you are sectioning 
through. Previous studies that have employed typical histochemistry analysis techniques to 
image DRGs have been limited in their ability to isolate individual macrophages due to their 
amorphic structure.  Because macrophages exist in unique shapes with erratic skinny processes 
(Nascimento et al., 2018) that can show up as separate from their cell body (e.g. from noise and 
imaging confines), they can appear in and out of a single plane, distorting accurate 
representations of morphological nuances and lead to miscounting. Therefore, the analysis of 
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many individual sections would be required to achieve a meaningful sample using typical 
histochemistry methods and may still limit the ability to detect whole-cell morphological and 
contextual information that accurately informs how macrophages change and interact with their 
environment with regard to changes in the DRG following injury. However, the DRG being 




Wild type C57/BI6 and Ccr2-/- functional knock out mice were used in this study. Mice 
were housed with a maximum of three other mice. Ccr2-/- mice lack the gene that encodes for 
chemokine receptor that is responsible for recruiting macrophages to the DRG (Yu et al., 2020). 
All experimentation and animal care dimensions were approved by the Institutional Animal Care 
and Use Committee of UC San Diego.  
Intrathecal drug delivery 
Mice were anaesthetized using 2-3% isoflurane until breathing substantially slowed and 
behavioral responses were inhibited. 50uL of stock Lipopolysaccharide (LPS) solution (2mg/ml 
stored at -20 degrees Celsius) was diluted to a concentration of 0.2 ug/ul by combining a ratio of 
10 ul stock/90uL saline. 
Intrathecal (IT) injections were administered using a 25 ul Hamilton syringe that was 
attached to a 30g needle by polyethylene tubing. Devices were flushed with sterile water before 
injections. Slowly, 5 ul of LPS solution was injected between the L4-L5 intervertebral-space 
until the mouse’s tail observably twitched. If air bubbles appeared in the tubing, it was recorded 
and noted as impeded flow. 




Mice were deeply anesthetized with isoflurane and then administered a 0.1 ml dose of 
intraperitoneal Beuthenasia. Following the effective euthanization of mice with Beuthenaia, they 
were transcardially perfused using ice cold saline and 4% PFA. For the proceeding 24 hours 
mice were post-fixed in 4% PFA and then immediately stored in a PBS that included 0.02% 
sodium azide.  
Laminectomy of the vertebral column exposed the spinal cord and DRGs. DRGs 
corresponding to the sciatic nerve were identified in L3-5. During DRG collection, 0.5-1 cm of 
the peripheral nerve and the dorsal root surrounding the DRG were left in-tact to prevent damage 
to any cell body rich portions of the DRGs. Tissue damage can distort precise imaging. 
Design and materials for imaging chambers 
 In order to avoid tissue damage caused by sectioning the organ, imaging chambers were 
uniquely tailored to analyze whole mounted DRGs on inverted confocal microscope. Due to 
previous comparisons, we determined SLA printers using 3Dresyn CR UHT as the best DRG 
imaging chamber. The chambers were perfectly flat and were able to be reused for the longest 
time: they did not degrade with over 100 uses. SLA chambers also never fell of the slides even 
when glued with low viscosity cyanoacrylate. 
Tissue clearing for immunohistochemistry 
A slightly modified version of the iDISCO and fDISCO protocols were employed to clear 
and stain the DRG tissues. Because DRGs are anatomically small, pretreatment was not always 
necessary and if avoidable, tissue working time was greatly reduced. DRGs were stained with 
Iba1 (wacko, 1:1000), CD-31( ,1:50), NeuN ( 1:300), mCherry(Rockland, 1:1000), and 
DAPI(1:10,000). DRGs were always washed in metal plates with transfer baskets and 
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incubations were carried out in securely sealed Eppendorf tubes of glass vials. DRGs were 
washed three times for 15 minutes each in PTx.2 and then incubated in permeabilization solution 
for 2 hours at 37 degrees Celsius on a shake plate. The DRGs were then transferred to blocking 
solutions, on a shake plate, for two hours at 37 degrees Celsius. Following, DRGs were 
incubated for 24-72 hours in a 1 degree antibody on a shake plate at 37 degrees Celsius. 
Combining multiple DRGs in the same clearing process helped save reagents but required larger 
(1.5 ml) Eppendorf tubes. With individual DRGs, PCR tubes with 200 microliters of solution 
sufficed. DRGs were then washed five more times in 15 minute durations with PTwH. For the 
following 24-72 hours, DRGs were incubated on a shake plate in a secondary antibody solution 
(PTwH/3% serum) at 37 degrees Celsius. Lastly, the DRGs were washed for one to two hours in 
PTwH + DAPI 1:10,000, and then washed five times in 15 minute durations with PTwH prior to 
clearing. 
 THF proved to be a better reagent for tissue clearing compared to menthol but posed 
methodological challenges as it cannot be stored in plastic vials. Accordingly, DRGs were 
dehydrated in a series of glass vials containing THF/H2O at the following concentrations: 
50%,70%,80%,100%, 100%, Then DCM 33%/THF 66%, 100%DCM, and finally 100% DBE. 
 When using DBE, some slight shrinkage of the DRG can occur. Volumetric reduction of 
the DRG can be beneficial in assuring that the working distance of the magnification objective 
spans the depths of the DRG. Notably, upon DRG submersion in BDE, the structure becomes 
invisible and can be lost. As a preventative measure, DAPI was added so that a weak UV light 
could be used (along with UV glasses) to visualize the DRG. BDE can be used to store DRGs 
but the length that it can store DRGs depends on the temperature in which it is kept. 
Imaging 
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 Inverted SP5 confocal microscopes with 10x air, 20x air, and 63x water objectives have a 
working distance greater than the depth of the DRG. These machines were employed to obtain 
high resolution images of the DRG that controlled for photo bleaching and loss of fluorescent 
intensity at deep tissue depths by optimizing settings at the lowest laser signal intensity that 
effectively produced signal.  
10 image analysis pipeline 
Traditional imaging methods failed to accurately quantify macrophage activation states 
and 3D datasets (DRG tissue) were largely limited due to the inaccessibility of advanced imaging 
software. Despite being extremely expensive and time-consuming (as you must set specific 
thresholds for signal and noise in each image), Imaris was used for the manual detection of 
individual macrophages as it is a commercially available and validated cell-labeling method. I 
acted as a trained and expert observer in the identification of macrophages by isolating signal 
from noise in DRG images taken from different depths, with different intensities, and under 
different conditions (Figure 3.a). 
Emphasis was given to track 
processes throughout stacks of tissue 
images to capture macrophage 
morphology across image planes. 
These labels were used as a ground 
truth for training data and were 
supposed to encompass all of the 
possible data that the model would 
encounter while analyzing DRGs.  
Figure 3: A. raw images of DRG tissue at different depths and intensities 
were analyzed. An expert observer differentiated between signal (green) and 
noise (blue). The labeled images were used as ground truth for training the 
model. B. accuracy increased and loss reduced after training the model over 
2000 epochs. C. Model predictions reflected macrophages (green) and 
background (blue). 
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The machine learning program was trained to recognize macrophages as the expert 
observer did, among stacks of 30 images that contained 5-10 labeled macrophages per image. 
These models were trained for up to 2000 epochs and resulted in highly reproducible and 
accurate predictions (Figure 3.b). The model takes raw macrophage images as an input and 
outputs individual macrophage data in binary. This methodology serves to reduce bias in cell 
labeling as the trained labeler did not know what population of macrophages they were exposed 
to (e.g. WT, LPS, Ccr2-/-, Ccr2-/- and LPS tissues). Future applications of this model would 
further reduce human bias that is inherent in the expensive and time-consuming individual 
labeling of cells through Imaris. 
Expanding upon the 3D modeling techniques stated above, we employed a pipeline to 
segment our raw image-labeled macrophages, and reconstruct the original raw images, ultimately 
enabling us to view macrophages through their 3D morphological features, staining intensity, 
and the type of cells that they were in contact with. To accomplish this, we strung together raw a 
pipeline in the form of a shell 
script that takes raw images and 
runs them through the machine 
learning models, then 
subsequently segments and 
analyzes the resulting outputs.  
In accordance with our 
interest in the DRG vasculature 
and its interactions with 
macrophages, the pipeline was Figure 4: Visual representationof image analysis pipeline. Top row: input and output 
of Iba1 stained DRGs showing the average raw image Z projection and the 3D 
rendering of randomly colored macrophages. Bottom row: input and output of raw 
Iba1 positive macrophages and CD31 labelled blood vessels. The pipeline output 
classifies macrophages as perivascular (yellow) or non-perivascular (cyan) based on 
their proximity to blood vessels. 
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designed to explicitly identify macrophages and then classify those macrophages as perivascular 
(in physical contact with a blood vessel), or non-perivascular, based on their contact with blood 
vessels. The model then quantified macrophage volume, number, and image characteristics (e.g. 
intensity, depth) based on 3D representations of whole cells. A visual representation of these 
functions is shown in figure 4. 
 
Results 
The goal of the present study was to validate a novel 3D imaging technique that would 
capture morphological changes that occur in the DRG following IT LPS, maintaining the 
accurate depiction of cellular complexity through whole-cell identification.  
Distinct populations of macrophages in the DRG, the sciatic nerve (SN), and the spinal 
cord (SC) 
The study illustrated in Figure 5 was done as preliminary research generated in the Yaksh 
laboratory, using standard multiparametric flow cytometric sample processing and data analysis 
methodologies. Fresh tissues from the mouse DRG, SN, and the SC were each disaggregated and 
evaluated separately by multiparametric flow cytometry, using antibodies to the macrophage-
associated antigens CD45, CD64, CD11b, MHCII, CX3CR1, and F4/80, plus propidium iodide 
(PI) as a viability marker. Figure 5.a shows that when the analysis is restricted to the CD45-
positive/PI-negative cells in each of these three locations, two discrete macrophage subsets are 
identifiable by virtue of their differing levels of expression of CD64, F4/80, MHCII, and CD11b 
when the flow data are visualized on 2-dimensional dotplots; all of the macrophages express 
similarly high levels of Cx3Cr1 (Figure 5.b), the fraktaline ligand and chemokine receptor that 
specifically defines peripheral monocytic cells (Yu et al., 2020). When t-distributed stochastic 
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neighbor embedding (t-SNE, a machine learning algorithm for visualization of high-dimensional 
data a low-dimensional space of two or three dimensions) is applied to the data (Figure 5.c), the 
presence of two discrete macrophage subsets is confirmed, with one subset (colored black Figure 
5.c) being largely limited to the spinal cord (CNS origin), and the other subset consisting of both 
DRG and sciatic nerve components (both of PNS origin).  Figure 5.d (left) shows the different 
macrophage densities in these three anatomic locations, with the highest density of macrophages 
being in the spinal cord, and the lowest density being in the sciatic nerve.  Finally, when green 
fluorescent protein (GFP)-tagged Cx3Cr1 can be used to visualize the tissue distribution of 
macrophages in these three locations (Figure 5.d, right) 
Figure 5: Figure 4: Distinct populations of macrophages reside in the DRG, the sciatic nerve (SN), and the spinal cord 
(SC). A, B: Flow cytometric evaluation of known macrophage markers in disaggregated samples from these 3 
locations. Flow cytometry of WT (a) and Cx3CR1-gfp mouse tissues (b) quantified the presence of these markers and 
accordingly pictured macrophage populations.  C. t-SNE plots show cells with similar characteristics as distinct 
clusters in Cartesian space, allowing visualization of two distinct macrophage populations. D, left. Graphs illustrate a 
significant difference in the number of CD45 positive and CD64+F4/80 macrophages present in the DRG, SN, and 
SC. D, right. Visual representation of Cx3cr1-GFP+CCR2-RFP positive macrophages. 
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DRG Macrophage activation following intrathecal LPS 
 Intrathecal LPS administration was used authenticate the functionality of the imaging 
methods and pipeline. A visual difference of macrophage morphology was observed as a larger 
volume of Iba1 positive cells were present in the DRG of mice injected with IT LPS compared to 
those injected with saline (Figure 6.a). Ccr2-/- mice were also injected with IT LPS to assess 
macrophage infiltration of the DRG after nerve injury. In Ccr2-/- mice, a chemokine receptor 
that is crucial for the recruitment of macrophages during immune responses in deleted.  
Therefore, the observed increase in macrophage size and volume in Ccr2-/- mice 
following IT LPS indicates that macrophage expansion in the DRG is more likely to occur by 
local proliferation than by the infiltration of circulating macrophages.  
The results of our pipeline indicate that DRG macrophage volume increases after IT LPS 
in both WT and Ccr2-/- mice (figure 6.c). The data produced by our pipeline replicated Imaris 
results, confirming the validity of the present imaging methods (Figure 6.b and 6.c). Our pipeline 
also enabled the accurate counting of macrophages by number in the DRG which showed no 
increase in the number of macrophages in the DRG after IT LPS (Figure 6.d).  
The model was able to identify significant volumetric increases of both non-perivascular 
macrophages (Figure 6.e) and perivascular macrophages (Figure 6.f) following IT LPS. 
Significant increases in the volume of non-perivascular macrophages, perivascular macrophages, 
and all macrophages were observed in the DRGs of mice treated with LPS compared to saline 
(Figure 6.g, 6.h, and 6.i).  This change was larger in perivascular macrophages, suggesting that 
macrophage-vessel interactions in the DRG have some unique function or role in mediating pain 
transmission. 




Many studies have examined macrophages in the DRG through fluorescence-activated 
cell sorting (FACS) and flow cytometry (Yu et al., 2020), but these studies have lacked the 
ability to access complex 3D morphology of macrophage projections in the densely packed DRG 
environment. In our study, flow cytometry provided important preliminary evidence for the 
existence of a distinct macrophage population in the DRG, while comparison to the imaging 
Figure 6: The effect of IT LPS on macrophage activation in the DRG. A. Visual representation of macrophages in 
WT and CCR2-/- mice. B. Analysis with Imaris reflected an increase in macrophage volume in following IT LPS 
in C57/BI6 and CCR2-/- mice. C. Analysis with our pipeline replicates data produced by Imaris. D. No change 
was observed in the number of macrophages present in the DRG before and after IT LPS. E, F, G, H. significant 
increases were observed in non-perivascular and perivascular macrophages following IT LPS. I. macrophages 
increase in volume following IT LPS. [**** P<0.0001]   
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program Imaris enabled us to develop our own method to quantify labeled agents in the DRG in 
a pain state, and to assess 3D cell-cell interactions (such as those between blood cells and 
macrophages). In the present study, we present a novel, efficient, and informative way to 
process, stain, and image DRGs using high-resolution confocal microscopy and a novel pipeline 
that enables the analysis of large stacks of high quality 3D images.  
The pipeline we created was validated by confirming the significant apparent changes in 
macrophage morphology, in response to IT LPS (immune mediated pain) that were expected 
based on previous research that was summarized in the introduction. LPS activated macrophages 
in tests on WT and CCR2 knockout mice. Further proof of our pipeline was demonstrated as it 
replicated data produced by Imaris, a commercially available and widely used imaging program 
(Figure 5.c). While useful, Imaris is expensive, time consuming, and labor intensive. It also 
reflects more potential bias introduced due to exhaustive involvement by human labelers. Our 
pipeline reduced bias and let us see the greater complexity of 3D images. 
These results demonstrate the complexity of the DRG and macrophage activation after 
LPS exposure. Our data suggests that previous studies that have employed traditional histology 
techniques have had the limitations inherent to imaging amorphous cells using slice histology. 
Because larger macrophages with more projections could pass in and out of sectioned planes 
(slices) and appear as separate from the cell body they belong to, traditional histologic analysis 
risks quantifying more macrophages than are actually present. 
In contrast with previous research, we observed that distinct populations of macrophages 
in the DRG do not proliferate following nerve injury, but rather significantly increase in volume. 
Volumetric increases in DRG macrophages holds true for WT and CCR2-/- mice that lack 
infiltrating monocytes and macrophages (Figure 6.b). This result indicates that volumetric 
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macrophage increases occur in pre-existing DRG macrophage populations, and do not reply on 
external macrophages that infiltrate the DRG.  
In contrast to the slow-onset, adaptive immune response that is entirely based on T-
lymphocytes, macrophages are part of our innate immune response that uses non-specific 
defense mechanisms immediately or shortly after the appearance of an antigen in the body. 
Innate immune signaling, as initiated by the activation of TLR4 receptors by LPS may drive 
activation of DRG macrophages and cause the release of products into the DRG that excite DRG 
somas, resulting in ongoing ectopic activity arising from the DRG. While the direct effect of 
macrophage activation was not examined in this study, it has been suggested that macrophages 
release more pro-inflammatory mediators when they are activated (as evidenced by their increase 
in volume) (Xie et al., 2007; Hu & McLachlan, 2002). 
The pipeline demonstrated in this study illustrates the power of using machine learning to 
analyze large stacks of 3D data and visualize macroscopic processes that occur in the body. The 
same methods and techniques presented here can be applied to future studies investigating the 
specific cellular mechanisms that underlie behavioral phenomena. Potential basic science topics 
of interest related to the DRG include the expression and release of mediators from the neuronal 
soma, cell-cell interactions, and environmental characteristics including relationship to the 
vasculature. Potential clinical topics of interest related to the role of DRG macrophages in 
chronic pain include isolating the casual relationship between macrophage morphology and 
afferent sensitization (e.g. do macrophages cause persistent pain or are they merely a symptom of 
it?), analyzing of DRG macrophage changes across a variety of different pain states, and 
evaluating the clinical relevance of macrophage manipulation on persistent pain. Furthering our 
understanding of the influential components of pain processing should uncover specialized and 
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